“Mechanisms of siRNA-Mediated Gene Silencing in Mammalian Cells”

Small interfering RNA (siRNA) is a widely used molecular tool that enables specific gene silencing by harnessing the natural RNA interference (RNAi) pathway. This process begins when synthetic siRNA molecules, typically 21 to 23 nucleotides in length with characteristic 3′ overhangs, are introduced into the cytoplasm of mammalian cells. Once inside, these siRNA duplexes are recognized by a protein complex known as the RNA-induced silencing complex (RISC). Within this complex, one strand of the siRNA, called the guide strand, is incorporated while the complementary passenger strand is degraded.

The guide strand then directs RISC to bind complementary messenger RNA (mRNA) molecules based on sequence complementarity. Upon binding, the Argonaute 2 (AGO2) protein within the RISC complex catalyzes the cleavage of the target mRNA, marking it for degradation. This cleavage prevents the mRNA from being translated into protein, effectively silencing the gene. The degradation of mRNA fragments is completed by cellular exonucleases, ensuring the message is irreversibly destroyed. Because each RISC complex loaded with guide strand can repeatedly target multiple mRNA molecules, siRNA-mediated gene silencing is highly efficient even at low siRNA concentrations.

Several factors influence the effectiveness of siRNA-mediated silencing. The thermodynamic properties of the siRNA duplex affect which strand is selected as the guide strand. The secondary structure and GC content of the target mRNA can impact the accessibility of the binding site. Chemical modifications to the siRNA molecule can enhance its stability in the cellular environment and reduce unintended immune responses. Additionally, the method used to deliver siRNA into cells, as well as the particular cell type being targeted, can significantly affect the localization and incorporation of siRNA into the RNAi machinery.

By selectively silencing specific genes, siRNA technology allows researchers to explore gene function, dissect signaling pathways, and develop disease models. It also holds promise in therapeutic development, where targeted gene knockdown can induce desired cellular responses such as apoptosis or cell cycle arrest. Because of its specificity, reversibility, and adaptability, siRNA has become a critical tool in functional genomics and personalized medicine research.

References: Altogen.com Altogenlabs.com